SCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups

BACKGROUND: Efficacy of house dust mite (HDM) allergen immunotherapy (AIT) in allergic rhinitis and controlled allergic asthma has been documented in controlled trials with adults and children. However, tolerability comparing clinical development and post marketing data, particularly in different su...

Descripción completa

Detalles Bibliográficos
Autores principales: Klimek, Ludger, Fox, Gabriele-Cornelia, Thum-Oltmer, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153715/
https://www.ncbi.nlm.nih.gov/pubmed/30294519
http://dx.doi.org/10.1007/s40629-018-0059-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153715/
https://www.ncbi.nlm.nih.gov/pubmed/30294519
http://dx.doi.org/10.1007/s40629-018-0059-x

Ejemplares similares